Bank Of America Corp Axsome Therapeutics, Inc. Call Options Transaction History

Bank Of America Corp

  • $1.33 Trillion
  • Q2 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$83.08 - $100.49 $12 Million - $14.5 Million
144,000 Added 7200.0%
146,000 $12.4 Million
Q2 2024

Aug 14, 2024
BUY
$65.72 - $80.5 $32,860 - $40,250
500 Added 33.33%
2,000 $161,000
Q1 2024

May 15, 2024
BUY
$69.39 - $97.64 $104,085 - $146,460
1,500 New
1,500 $119,000

Others Institutions Holding AXSM

# of Institutions
401
Shares Held
37.3M
Call Options Held
524K
Put Options Held
539K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.51B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email